Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 17 studies | 34% ± 19% | |
peripheral blood | 14 studies | 30% ± 8% | |
intestine | 11 studies | 37% ± 20% | |
kidney | 8 studies | 33% ± 13% | |
bone marrow | 6 studies | 25% ± 11% | |
pancreas | 5 studies | 46% ± 21% | |
lymph node | 5 studies | 25% ± 8% | |
liver | 5 studies | 35% ± 19% | |
placenta | 4 studies | 54% ± 20% | |
eye | 4 studies | 20% ± 4% | |
uterus | 4 studies | 48% ± 20% | |
breast | 4 studies | 30% ± 4% | |
brain | 4 studies | 21% ± 2% | |
adrenal gland | 3 studies | 24% ± 3% | |
skin | 3 studies | 28% ± 3% | |
thymus | 3 studies | 53% ± 27% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2317.21 | 1445 / 1445 | 100% | 114.72 | 183 / 183 |
liver | 100% | 4085.50 | 226 / 226 | 100% | 146.82 | 406 / 406 |
lung | 100% | 3122.16 | 578 / 578 | 100% | 194.15 | 1155 / 1155 |
ovary | 100% | 2993.54 | 180 / 180 | 100% | 151.96 | 430 / 430 |
pancreas | 100% | 3341.82 | 328 / 328 | 100% | 172.18 | 178 / 178 |
skin | 100% | 4215.93 | 1808 / 1809 | 100% | 197.93 | 472 / 472 |
breast | 100% | 2784.38 | 459 / 459 | 100% | 207.97 | 1117 / 1118 |
bladder | 100% | 2598.19 | 21 / 21 | 100% | 173.74 | 503 / 504 |
uterus | 100% | 2880.49 | 170 / 170 | 100% | 198.34 | 458 / 459 |
stomach | 100% | 2375.23 | 359 / 359 | 100% | 143.23 | 285 / 286 |
intestine | 100% | 2551.41 | 966 / 966 | 100% | 166.96 | 525 / 527 |
prostate | 100% | 2407.31 | 245 / 245 | 100% | 168.63 | 500 / 502 |
thymus | 100% | 2716.27 | 653 / 653 | 99% | 140.20 | 601 / 605 |
kidney | 100% | 2457.85 | 89 / 89 | 99% | 131.02 | 892 / 901 |
adrenal gland | 100% | 3249.73 | 258 / 258 | 98% | 107.81 | 225 / 230 |
brain | 92% | 836.44 | 2438 / 2642 | 97% | 82.30 | 685 / 705 |
adipose | 100% | 2897.53 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 104.54 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 142.57 | 29 / 29 |
spleen | 100% | 3188.04 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 145.27 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 129.31 | 1 / 1 |
blood vessel | 100% | 2790.53 | 1332 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 1468.30 | 835 / 861 | 0% | 0 | 0 / 0 |
muscle | 79% | 587.86 | 635 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 79% | 1793.30 | 731 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0018279 | Biological process | protein N-linked glycosylation via asparagine |
GO_0006487 | Biological process | protein N-linked glycosylation |
GO_0008250 | Cellular component | oligosaccharyltransferase complex |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0004579 | Molecular function | dolichyl-diphosphooligosaccharide-protein glycotransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | OSTC |
Protein name | Oligosaccharyltransferase complex subunit OSTC (Hydrophobic protein HSF-28) Oligosaccharyltransferase complex subunit |
Synonyms | DC2 HSPC307 HDCMD45P |
Description | FUNCTION: Specific component of the STT3A-containing form of the oligosaccharyl transferase (OST) complex that catalyzes the initial transfer of a defined glycan (Glc(3)Man(9)GlcNAc(2) in eukaryotes) from the lipid carrier dolichol-pyrophosphate to an asparagine residue within an Asn-X-Ser/Thr consensus motif in nascent polypeptide chains, the first step in protein N-glycosylation . N-glycosylation occurs cotranslationally and the complex associates with the Sec61 complex at the channel-forming translocon complex that mediates protein translocation across the endoplasmic reticulum (ER). All subunits are required for a maximal enzyme activity. May be involved in N-glycosylation of APP (amyloid-beta precursor protein). Can modulate gamma-secretase cleavage of APP by enhancing endoprotelysis of PSEN1. . FUNCTION: Specific component of the STT3A-containing form of the oligosaccharyl transferase (OST) complex that catalyzes the initial transfer of a defined glycan (Glc(3)Man(9)GlcNAc(2) in eukaryotes) from the lipid carrier dolichol-pyrophosphate to an asparagine residue within an Asn-X-Ser/Thr consensus motif in nascent polypeptide chains, the first step in protein N-glycosylation. N-glycosylation occurs cotranslationally and the complex associates with the Sec61 complex at the channel-forming translocon complex that mediates protein translocation across the endoplasmic reticulum (ER). All subunits are required for a maximal enzyme activity. May be involved in N-glycosylation of APP (amyloid-beta precursor protein). Can modulate gamma-secretase cleavage of APP by enhancing endoprotelysis of PSEN1. . |
Accessions | Q9NRP0 ENST00000613215.4 ENST00000512478.2 [Q9NRP0-2] ENST00000361564.9 [Q9NRP0-1] A0A087WUD3 |